Evolus, Inc.
NASDAQ:EOLS
12.68 (USD) • At close March 10, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 264.306 | 202.085 | 148.616 | 99.673 | 56.54 | 34.925 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 83.97 | 61.559 | 55.887 | 43.534 | 18.299 | 8.014 | 0.009 | 0.218 | 0.326 | 0.416 |
| Gross Profit
| 180.336 | 140.526 | 92.729 | 56.139 | 38.241 | 26.911 | -0.009 | -0.218 | -0.326 | -0.416 |
| Gross Profit Ratio
| 0.682 | 0.695 | 0.624 | 0.563 | 0.676 | 0.771 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 9.172 | 15.425 | 4.742 | 2.064 | 1.722 | 3.973 | 6.487 | 6.689 | 12.607 | 20.681 |
| General & Administrative Expenses
| 0 | 157.454 | 130.198 | 0 | 0 | 0 | 29.146 | 4.819 | 7.033 | 9.883 |
| Selling & Marketing Expenses
| 0 | 7.49 | 11.642 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 198.025 | 164.944 | 141.84 | 112.068 | 98.19 | 113.593 | 29.146 | 4.819 | 7.033 | 9.883 |
| Other Expenses
| 9.518 | 9.39 | 3.722 | 5.622 | 7.027 | 4.132 | -10.5 | -0.005 | -0.006 | -0.039 |
| Operating Expenses
| 216.715 | 189.759 | 150.304 | 119.754 | 106.939 | 121.698 | 35.642 | 11.726 | 19.966 | 30.98 |
| Operating Income
| -34.411 | -49.233 | -57.575 | -63.615 | -68.698 | -94.787 | -46.142 | -11.726 | -19.966 | -30.98 |
| Operating Income Ratio
| -0.13 | -0.244 | -0.387 | -0.638 | -1.215 | -2.714 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -15.345 | -12.276 | -8.987 | -2.363 | -9.868 | -6.114 | -0.66 | -0.005 | -0.006 | -0.039 |
| Income Before Tax
| -49.756 | -61.509 | -74.317 | -46.768 | -162.936 | -105.061 | -46.802 | -11.731 | -19.972 | -31.019 |
| Income Before Tax Ratio
| -0.188 | -0.304 | -0.5 | -0.469 | -2.882 | -3.008 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.664 | 0.176 | 0.095 | 0.042 | 0.077 | -15.027 | 0.065 | -7.251 | 0.093 | 0.093 |
| Net Income
| -50.42 | -61.685 | -74.412 | -46.81 | -163.013 | -90.034 | -46.867 | -4.48 | -20.065 | -31.112 |
| Net Income Ratio
| -0.191 | -0.305 | -0.501 | -0.47 | -2.883 | -2.578 | 0 | 0 | 0 | 0 |
| EPS
| -0.81 | -1.08 | -1.33 | -0.94 | -4.83 | -3.19 | -1.92 | -0.19 | -1.08 | -1.67 |
| EPS Diluted
| -0.81 | -1.08 | -1.33 | -0.94 | -4.83 | -3.19 | -1.92 | -0.19 | -1.08 | -1.67 |
| EBITDA
| -25.001 | -41.81 | -60.723 | -39.058 | -144.752 | -92.103 | -46.133 | -11.508 | -19.64 | -30.564 |
| EBITDA Ratio
| -0.095 | -0.207 | -0.4 | -0.645 | -1.044 | -2.662 | 0 | 0 | 0 | 0 |